240 related articles for article (PubMed ID: 20018952)
1. Tetramerization domain mutations in KCNA5 affect channel kinetics and cause abnormal trafficking patterns.
Burg ED; Platoshyn O; Tsigelny IF; Lozano-Ruiz B; Rana BK; Yuan JX
Am J Physiol Cell Physiol; 2010 Mar; 298(3):C496-509. PubMed ID: 20018952
[TBL] [Abstract][Full Text] [Related]
2. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
Remillard CV; Tigno DD; Platoshyn O; Burg ED; Brevnova EE; Conger D; Nicholson A; Rana BK; Channick RN; Rubin LJ; O'connor DT; Yuan JX
Am J Physiol Cell Physiol; 2007 May; 292(5):C1837-53. PubMed ID: 17267549
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of human KCNA5 increases IK V and enhances apoptosis.
Brevnova EE; Platoshyn O; Zhang S; Yuan JX
Am J Physiol Cell Physiol; 2004 Sep; 287(3):C715-22. PubMed ID: 15140747
[TBL] [Abstract][Full Text] [Related]
4. Acute hypoxia selectively inhibits KCNA5 channels in pulmonary artery smooth muscle cells.
Platoshyn O; Brevnova EE; Burg ED; Yu Y; Remillard CV; Yuan JX
Am J Physiol Cell Physiol; 2006 Mar; 290(3):C907-16. PubMed ID: 16236819
[TBL] [Abstract][Full Text] [Related]
5. Normal targeting of a tagged Kv1.5 channel acutely transfected into fresh adult cardiac myocytes by a biolistic method.
Dou Y; Balse E; Dehghani Zadeh A; Wang T; Goonasekara CL; Noble GP; Eldstrom J; Steele DF; Hatem SN; Fedida D
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1343-52. PubMed ID: 20357183
[TBL] [Abstract][Full Text] [Related]
6. Four and a half LIM protein 1: a partner for KCNA5 in human atrium.
Yang Z; Browning CF; Hallaq H; Yermalitskaya L; Esker J; Hall MR; Link AJ; Ham AJ; McGrath MJ; Mitchell CA; Murray KT
Cardiovasc Res; 2008 Jun; 78(3):449-57. PubMed ID: 18281375
[TBL] [Abstract][Full Text] [Related]
7. Amino-terminal determinants of U-type inactivation of voltage-gated K+ channels.
Kurata HT; Soon GS; Eldstrom JR; Lu GW; Steele DF; Fedida D
J Biol Chem; 2002 Aug; 277(32):29045-53. PubMed ID: 12021261
[TBL] [Abstract][Full Text] [Related]
8. The anchoring protein SAP97 retains Kv1.5 channels in the plasma membrane of cardiac myocytes.
Abi-Char J; El-Haou S; Balse E; Neyroud N; Vranckx R; Coulombe A; Hatem SN
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1851-61. PubMed ID: 18245566
[TBL] [Abstract][Full Text] [Related]
9. miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries.
Mondejar-Parreño G; Callejo M; Barreira B; Morales-Cano D; Esquivel-Ruiz S; Moreno L; Cogolludo A; Perez-Vizcaino F
J Physiol; 2019 Feb; 597(4):1185-1197. PubMed ID: 29717493
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia selectively inhibits KCNA5 channels in pulmonary artery smooth muscle cells.
Firth AL; Platoshyn O; Brevnova EE; Burg ED; Powell F; Haddad GH; Yuan JX
Ann N Y Acad Sci; 2009 Oct; 1177():101-11. PubMed ID: 19845612
[TBL] [Abstract][Full Text] [Related]
11. Effect of K+ and Rb+ on the action of verapamil on a voltage-gated K+ channel, hKv1.3: implications for a second open state?
Kuras Z; Grissmer S
Br J Pharmacol; 2009 Jul; 157(5):757-68. PubMed ID: 19371328
[TBL] [Abstract][Full Text] [Related]
12. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages.
Vicente R; Escalada A; Villalonga N; Texidó L; Roura-Ferrer M; Martín-Satué M; López-Iglesias C; Soler C; Solsona C; Tamkun MM; Felipe A
J Biol Chem; 2006 Dec; 281(49):37675-85. PubMed ID: 17038323
[TBL] [Abstract][Full Text] [Related]
13. Molecular Determinants of Kv1.3 Potassium Channels-induced Proliferation.
Jiménez-Pérez L; Cidad P; Álvarez-Miguel I; Santos-Hipólito A; Torres-Merino R; Alonso E; de la Fuente MÁ; López-López JR; Pérez-García MT
J Biol Chem; 2016 Feb; 291(7):3569-80. PubMed ID: 26655221
[TBL] [Abstract][Full Text] [Related]
14. Kinetic Aspects of Verapamil Binding (On-Rate) on Wild-Type and Six hKv1.3 Mutant Channels.
Diesch AK; Grissmer S
Cell Physiol Biochem; 2017; 44(1):172-184. PubMed ID: 29131061
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational modification of voltage-dependent potassium channel Kv1.5: COOH-terminal palmitoylation modulates its biological properties.
Jindal HK; Folco EJ; Liu GX; Koren G
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2012-21. PubMed ID: 18344374
[TBL] [Abstract][Full Text] [Related]
16. Decreased Kv1.5 expression in intrauterine growth retardation rats with exaggerated pulmonary hypertension.
Lv Y; Tang LL; Wei JK; Xu XF; Gu W; Fu LC; Zhang LY; Du LZ
Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(11):L856-65. PubMed ID: 24077947
[TBL] [Abstract][Full Text] [Related]
17. Separation of P/C- and U-type inactivation pathways in Kv1.5 potassium channels.
Kurata HT; Doerksen KW; Eldstrom JR; Rezazadeh S; Fedida D
J Physiol; 2005 Oct; 568(Pt 1):31-46. PubMed ID: 16020465
[TBL] [Abstract][Full Text] [Related]
18. Novel Loss-of-Function
Vera-Zambrano A; Lago-Docampo M; Gallego N; Franco-Gonzalez JF; Morales-Cano D; Cruz-Utrilla A; Villegas-Esguevillas M; Fernández-Malavé E; Escribano-Subías P; Tenorio-Castaño JA; Perez-Vizcaino F; Valverde D; González T; ; Cogolludo A
Am J Respir Cell Mol Biol; 2023 Aug; 69(2):147-158. PubMed ID: 36917789
[TBL] [Abstract][Full Text] [Related]
19. Studies of Conorfamide-Sr3 on Human Voltage-Gated Kv1 Potassium Channel Subtypes.
López-Vera E; Martínez-Hernández L; Aguilar MB; Carrillo E; Gajewiak J
Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32823677
[TBL] [Abstract][Full Text] [Related]
20. Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system.
Mullen KM; Rozycka M; Rus H; Hu L; Cudrici C; Zafranskaia E; Pennington MW; Johns DC; Judge SI; Calabresi PA
Ann Neurol; 2006 Jul; 60(1):118-27. PubMed ID: 16729292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]